Following the declaration of COVID-19 as a global public health threat, disease surveillance activities were crippled in 2020. Documenting surveillance improvements of Sidama region in 2021 has to be endorsed to boost the performances. A comparative analysis study design of acute flaccid paralysis and measles surveillance data of 2020 and 2021 for Sidama region was used. Two years all reports of AFP and suspected measles cases in 2020 and 2021 from Sidama region were used for this study. The non-polio AFP rate and stool adequacy rate were used to assess the sensitivity of the AFP surveillance. Whereas the non-measles febrile rash rate was used to assess the measles surveillance. A total of 91 AFP cases in 2021 and 44 in 2020 have been detected and investigated for polio analysis. All cases were discarded in both years. The stool adequacy rate for 2021 was 90.1%; whereas, 86.4% in 2020. Annualized non-polio AFP rate was 2.2/100,000 for 2020 and 3.8/100,000 for 2021, which the latter is much higher to the minimum expected rate in outbreak areas of 3/100,000. A total of 154 suspected measles cases in 2021 and 111 in 2020 have been investigated for IGM analysis. In 2020, 64 and 11 in 2021 IGM positive for measles were identified. The non-measles febrile rash rate for 2020 was 1.1/100,000; whereas 2.5/100,000 for 2021. There is an improvement in the sensitivity of AFP and measles surveillance performance for Sidama region in 2021. Sustaining high quality measles and AFP surveillance is suggested to maintain measles and polio free statuses.
| Published in | International Journal of Immunology (Volume 13, Issue 2) |
| DOI | 10.11648/j.iji.20251302.11 |
| Page(s) | 23-30 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Polio Eradication, Non-polio AFP Rate, Non-measles Febrile Rash, Acute Flaccid Paralysis, Measles
| [1] | WHO Director-General’s statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV). World Health Organization. |
| [2] | Interim guidance for the poliomyelitis (polio) surveillance network in the context of coronavirus disease (COVID19). Global Polio Eradication Initiative. |
| [3] | The Global Polio Laboratory Network. |
| [4] | Global Polio Surveillance Action Plan, 2018-2020. World Health Organization. |
| [5] |
Morbidity and Mortality weekly report. Centers for Disease control and prevention. MMWR / January 1, 2021 / Vol. 69 / No. 51-52.
https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm695152-H.pdf Accessed 20 March 2022. |
| [6] | Polio oversight board meeting summary. Global Polio Eradication Initiative. |
| [7] | Measles: vaccine preventable diseases, surveillance standards. World Health Organization., |
| [8] | Monitoring and Evaluation Unit & MCHN: Expanded Programme on Immunization. World Health Organization Ethiopia. AFP update for the Epidemiological Week 52 year 2021. |
| [9] | Monitoring and Evaluation Unit & MCHN: Expanded Programme on Immunization. World Health Organization Ethiopia. AFP update for the Epidemiological Week 52 year 2020. |
| [10] | Monitoring and Evaluation Unit & MCHN: Expanded Programme on Immunization. World Health Organization Ethiopia. Measles update for the Epidemiological Week 52 year 2021. |
| [11] | Monitoring and Evaluation Unit & MCHN: Expanded Programme on Immunization. World Health Organization Ethiopia. Measles update for the Epidemiological Week 52 year 2020. |
| [12] | Polio eradication programme continuity: implementation in the context of the COVID-19 pandemic Interim guide May 2020 update. World Health Organization. |
| [13] | Public health surveillance for COVID-19: interim guidance. World Health Organization. |
| [14] | Chard AN, Datta SD, Tallis G, et al. Progress toward polio eradication-worldwide, January 18–March 2020. MMWR Morb Mortal Wkly Rep. 2020; 69: 784–789. |
| [15] | Poliomyelitis: Vaccine Preventable Diseases Surveillance Standards. World Health Organization. |
| [16] | Monitoring and Evaluation Unit & MCHN: Expanded Programme on Immunization. World Health Organization Ethiopia. Polio update Week 52 year 2020. |
| [17] | Morbidity and Mortality Weekly Report (MMWR). Center for Disease Control and Prevention. Update on vaccine derived polio outbreak – worldwide, January 2020 – June 2021. Weekly. 2021; 70(49); 1691–1699. |
| [18] | Daudi Manyanga, Brine Masvikeni, Marybennah Kuloba, Charles Byabamazima, and Fussum Daniel. Early effects of the COVID-19 pandemic on the acute flaccid paralysis surveillance in East and Southern African countries. Pan Afr Med J. 2021; 39: 147. |
| [19] | Abdullahi Walla Hamisu, G. C. Onyemelukwe, Sume Etapelong Gerald, Isiaka Ayodeji Hassan, Braka Fiona, Richard Banda, Ajiboye Oyetunji, Alemu W & Faisal Shuaib. Gender Dimensions of Acute Flaccid Paralysis Surveillance in Nigeria. International Journal of Gender and Women’s Studies. 2017; Vol. 5, No. 2, pp. 80-87. |
| [20] | Momen A. A., Shakurnia, A. An epidemiological analysis of acute flaccid paralysis in Khuzestan Region, southwest Iran, from 2006 to 2010. Epidemiol. Health. 2010; 38: 1–5. |
| [21] | Belagavi Karnataka, Preet Khona, Abhishek Prayag, Girija S Ashtagi. Study of acute flaccid paralysis cases at tertiary care hospital, Belagavi, Karnataka. International Journal of Medical Science and Public Health. 2017; 6: 2. |
| [22] | Daudi Manyanga, Charles Byabamazima, Brine Masvikeni, Fussum Daniel. Assessment of acute flaccid paralysis surveillance performance in East and Southern African countries 2012 – 2019. Pan Afr Med J. 2020; 36: 71. |
| [23] |
Abu Ali KA. (2021) Acute Flaccid Paralysis surveillance in Gaza Strip, Palestine. Glob J Medical Clin Case Rep. 2021; 8: 2.
https://doi.org/ https://dx.doi.org/10.17352/2455-5282.000135 |
| [24] | Measles: Vaccine Preventable Diseases Surveillance Standards. World Health Organization. |
| [25] | Francis Muoka Ndonye et al. An evaluation of the measles surveillance system, and descriptive epidemiology of measles in Kenya (2020 – 2021). Journal of Interventional Epidemiology and Public Health. 2024; 7(4): 4. |
APA Style
Denegetu, A. W., Birru, T. G. (2025). Endorsing Improvements of AFP and Measles Surveillance Performances after the First COVID 19 Pandemic Lockdown (2020-2021), a Comparative Analysis Study Design: The Case of Sidama Region, Ethiopia. International Journal of Immunology, 13(2), 23-30. https://doi.org/10.11648/j.iji.20251302.11
ACS Style
Denegetu, A. W.; Birru, T. G. Endorsing Improvements of AFP and Measles Surveillance Performances after the First COVID 19 Pandemic Lockdown (2020-2021), a Comparative Analysis Study Design: The Case of Sidama Region, Ethiopia. Int. J. Immunol. 2025, 13(2), 23-30. doi: 10.11648/j.iji.20251302.11
AMA Style
Denegetu AW, Birru TG. Endorsing Improvements of AFP and Measles Surveillance Performances after the First COVID 19 Pandemic Lockdown (2020-2021), a Comparative Analysis Study Design: The Case of Sidama Region, Ethiopia. Int J Immunol. 2025;13(2):23-30. doi: 10.11648/j.iji.20251302.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.iji.20251302.11,
author = {Amenu Wesen Denegetu and Tadesse Gossaye Birru},
title = {Endorsing Improvements of AFP and Measles Surveillance Performances after the First COVID 19 Pandemic Lockdown (2020-2021), a Comparative Analysis Study Design: The Case of Sidama Region, Ethiopia
},
journal = {International Journal of Immunology},
volume = {13},
number = {2},
pages = {23-30},
doi = {10.11648/j.iji.20251302.11},
url = {https://doi.org/10.11648/j.iji.20251302.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.iji.20251302.11},
abstract = {Following the declaration of COVID-19 as a global public health threat, disease surveillance activities were crippled in 2020. Documenting surveillance improvements of Sidama region in 2021 has to be endorsed to boost the performances. A comparative analysis study design of acute flaccid paralysis and measles surveillance data of 2020 and 2021 for Sidama region was used. Two years all reports of AFP and suspected measles cases in 2020 and 2021 from Sidama region were used for this study. The non-polio AFP rate and stool adequacy rate were used to assess the sensitivity of the AFP surveillance. Whereas the non-measles febrile rash rate was used to assess the measles surveillance. A total of 91 AFP cases in 2021 and 44 in 2020 have been detected and investigated for polio analysis. All cases were discarded in both years. The stool adequacy rate for 2021 was 90.1%; whereas, 86.4% in 2020. Annualized non-polio AFP rate was 2.2/100,000 for 2020 and 3.8/100,000 for 2021, which the latter is much higher to the minimum expected rate in outbreak areas of 3/100,000. A total of 154 suspected measles cases in 2021 and 111 in 2020 have been investigated for IGM analysis. In 2020, 64 and 11 in 2021 IGM positive for measles were identified. The non-measles febrile rash rate for 2020 was 1.1/100,000; whereas 2.5/100,000 for 2021. There is an improvement in the sensitivity of AFP and measles surveillance performance for Sidama region in 2021. Sustaining high quality measles and AFP surveillance is suggested to maintain measles and polio free statuses.
},
year = {2025}
}
TY - JOUR T1 - Endorsing Improvements of AFP and Measles Surveillance Performances after the First COVID 19 Pandemic Lockdown (2020-2021), a Comparative Analysis Study Design: The Case of Sidama Region, Ethiopia AU - Amenu Wesen Denegetu AU - Tadesse Gossaye Birru Y1 - 2025/05/24 PY - 2025 N1 - https://doi.org/10.11648/j.iji.20251302.11 DO - 10.11648/j.iji.20251302.11 T2 - International Journal of Immunology JF - International Journal of Immunology JO - International Journal of Immunology SP - 23 EP - 30 PB - Science Publishing Group SN - 2329-1753 UR - https://doi.org/10.11648/j.iji.20251302.11 AB - Following the declaration of COVID-19 as a global public health threat, disease surveillance activities were crippled in 2020. Documenting surveillance improvements of Sidama region in 2021 has to be endorsed to boost the performances. A comparative analysis study design of acute flaccid paralysis and measles surveillance data of 2020 and 2021 for Sidama region was used. Two years all reports of AFP and suspected measles cases in 2020 and 2021 from Sidama region were used for this study. The non-polio AFP rate and stool adequacy rate were used to assess the sensitivity of the AFP surveillance. Whereas the non-measles febrile rash rate was used to assess the measles surveillance. A total of 91 AFP cases in 2021 and 44 in 2020 have been detected and investigated for polio analysis. All cases were discarded in both years. The stool adequacy rate for 2021 was 90.1%; whereas, 86.4% in 2020. Annualized non-polio AFP rate was 2.2/100,000 for 2020 and 3.8/100,000 for 2021, which the latter is much higher to the minimum expected rate in outbreak areas of 3/100,000. A total of 154 suspected measles cases in 2021 and 111 in 2020 have been investigated for IGM analysis. In 2020, 64 and 11 in 2021 IGM positive for measles were identified. The non-measles febrile rash rate for 2020 was 1.1/100,000; whereas 2.5/100,000 for 2021. There is an improvement in the sensitivity of AFP and measles surveillance performance for Sidama region in 2021. Sustaining high quality measles and AFP surveillance is suggested to maintain measles and polio free statuses. VL - 13 IS - 2 ER -
Maternal, Child Health and Nutrition Unit, World Health Organization Ethiopia, Addis Ababa, Ethiopia
Vaccine Preventable Diseases and Immunization Unit, World Health Organization Philippines, Manila, Philippines
Information